Summary: New research shows that MRI can help predict rectal cancer outcomes after chemotherapy and radiation, potentially allowing patients to avoid invasive surgery and its lifelong side effects.
Key Takeaways
- MRI can help predict whether rectal cancer patients can avoid invasive surgery by assessing the risk of tumor recurrence or spread after chemotherapy and radiation.
- The “watch-and-wait” approach, guided by MRI, offers an alternative to surgery, though some patients may feel uncertain about the potential for cancer to return.
- Combining MRI with endoscopy may further improve accuracy in predicting cancer outcomes, with ongoing research aiming for near-perfect predictive capabilities.
—————————————————————————————————————————————————————————————
New research suggests that MRI can help many rectal cancer patients avoid invasive surgery with potentially lifelong side effects.
The study, led by Arun Krishnaraj, MD, MPH, from University of Virginia Cancer Center, shows that MRI can predict outcomes and the risk of tumor recurrence or spread after chemotherapy and radiation. This helps doctors determine if patients can opt for a “watch-and-wait” approach instead of surgery. While some patients may experience uncertainty, MRI provides valuable information for both doctors and patients.
“After chemotherapy and radiation, patients worry about whether their cancer is completely gone,” says Krishnaraj. “Newer MRI techniques allow us to predict much more accurately whether any cancer remains or if it will return and spread. This helps patients and doctors decide who really needs surgery and who can avoid it.”
Better Care for Rectal Cancer
Colorectal cancer is increasing among adults under 50, while decreasing in older populations. The American Cancer Society estimates that 1 in 23 men and 1 in 25 women will be affected.
Radiation and chemotherapy are common treatments for rectal cancer, but some patients require “total mesorectal excision,” a surgery that can have major side effects, such as a permanent colostomy bag and sexual dysfunction.
To improve patient outcomes, Krishnaraj and his team studied the Organ Preservation in Rectal Adenocarcinoma trial. They reviewed MRI results from 277 patients, with an average age of 58, and followed their outcomes for over four years. The findings showed that MRI is effective in predicting overall survival, cancer recurrence, and the likelihood of patients avoiding surgery.
Combining MRI with endoscopy could make the approach even more effective, and the researchers are calling for further study. “Advancements in MRI and endoscopy could give us even better information about future outcomes,” Krishnaraj says. “Our goal is to get as close to 99% accuracy in predicting cancer recurrence and spread.”
